Banumathi Sankaran Selected Research

ophiocordin

1/2018

Structural basis for selective inhibition of human PKG Iα by the balanol-like compound N46.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Banumathi Sankaran Research Topics

Disease

7	COVID-19 10/2022 - 07/2020
7	Neoplasms (Cancer) 01/2022 - 09/2011
4	Infections 11/2019 - 06/2014
3	Gastroenteritis 01/2022 - 09/2011
3	Virus Diseases (Viral Diseases) 01/2021 - 04/2014
3	Bites and Stings (Sting) 01/2019 - 07/2013
2	Human Influenza (Influenza) 01/2020 - 11/2019
2	Communicable Diseases (Infectious Diseases) 01/2017 - 09/2011
2	Vascular System Injuries 06/2016 - 02/2016
1	Carcinogenesis 01/2021
1	Gram-Negative Bacterial Infections 01/2021
1	Obesity 01/2020
1	Pain (Aches) 01/2018
1	Hyperalgesia 01/2018
1	Chronic Pain 01/2018
1	von Willebrand Diseases (von Willebrand's Disease) 06/2016
1	Hemorrhage 06/2016
1	Type 2 von Willebrand Disease 02/2016
1	Cat-Scratch Disease 01/2016
1	Erectile Dysfunction 01/2016
1	Tuberculosis (Tuberculoses) 06/2015
1	Methylmalonic acidemia 06/2015
1	Diarrhea 12/2014
1	Botulism 07/2013
1	Malaria 09/2011
1	Babesiosis (Piroplasmosis) 09/2011
1	Starvation 11/2009

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2013
7	Pharmaceutical PreparationsIBA 10/2022 - 09/2011
5	Antiviral Agents (Antivirals)IBA 10/2022 - 04/2014
4	EnzymesIBA 10/2022 - 01/2019
4	Peptide Hydrolases (Proteases)FDA Link 10/2022 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 07/2013
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 10/2022 - 12/2021
2	Polysaccharides (Glycans)IBA 01/2022 - 09/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2021 - 07/2020
2	LigandsIBA 11/2019 - 01/2017
2	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 01/2018 - 01/2016
2	von Willebrand FactorIBA 06/2016 - 02/2016
2	Hemostatics (Antihemorrhagics)IBA 06/2016 - 02/2016
2	Blood Group Antigens (Blood Groups)IBA 06/2014 - 09/2011
1	Galectins (Galectin)IBA 01/2022
1	SARS-CoV-2 3C-like proteinaseIBA 12/2021
1	Klebsiella pneumoniae carbapenemase-2IBA 01/2021
1	Contraceptive Agents (Contraceptives)IBA 01/2021
1	Small Molecule LibrariesIBA 01/2021
1	Viral VaccinesIBA 01/2020
1	Hemagglutinins (Hemagglutinin)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	Interferon Type IIBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2019
1	Nucleic AcidsIBA 01/2019
1	ophiocordinIBA 01/2018
1	Ligases (Synthetase)IBA 01/2017
1	Transfer RNA (tRNA)IBA 01/2017
1	Amino Acids FDA Link 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Biological ProductsIBA 06/2016
1	4-hydroxy-tetrahydrodipicolinate synthase (dihydrodipicolinate synthase)IBA 01/2016
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2016
1	Virulence Factors (Pathogenicity Factors)IBA 12/2014
1	Triclosan (pHisoHex)FDA Link 11/2014
1	Oxidoreductases (Dehydrogenase)IBA 11/2014
1	Acyl Carrier ProteinIBA 11/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2014
1	InterferonsIBA 04/2014
1	Botulinum Toxins (Botulinum Toxin)IBA 07/2013
1	Thymidylate SynthaseIBA 09/2011
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 09/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2009

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2016
1	Drug Therapy (Chemotherapy) 09/2011